Abstract
The study of protein-drug interaction is of pivotal importance to understand the structural features essential for ligand affinity. The explosion of information about protein structures has paved the way to develop structure-based virtual screening approaches. Parasitic protein kinases have been pointed out as potential targets for antiparasitic development. The identification of protein kinases in the Plasmodium falciparum genome has opened the possibility to test new families of inhibitors as potential antimalarial drugs. In addition, other key enzymes which play roles in biosynthetic pathways, such as enoyl reductase and chorismate synthase, can be valuable targets for drug development. This review is focused on these protein targets that may help to materialize new generations of antimalarial drugs.
Keywords: Plasmodium falciparum, antimalarial drugs, structure-based virtual screening, protein kinases, enoyl reductase, chorismate synthase
Current Drug Targets
Title: Protein-Drug Interaction Studies for Development of Drugs Against Plasmodium falciparum
Volume: 10 Issue: 3
Author(s): Walter Filgueira de Azevedo Jr., Rafael Andrade Caceres, Ivani Pauli, Luis Fernando S.M. Timmers, Guy Barros Barcellos, Kelen Beiestorf Rocha and Milena Botelho Pereira Soares
Affiliation:
Keywords: Plasmodium falciparum, antimalarial drugs, structure-based virtual screening, protein kinases, enoyl reductase, chorismate synthase
Abstract: The study of protein-drug interaction is of pivotal importance to understand the structural features essential for ligand affinity. The explosion of information about protein structures has paved the way to develop structure-based virtual screening approaches. Parasitic protein kinases have been pointed out as potential targets for antiparasitic development. The identification of protein kinases in the Plasmodium falciparum genome has opened the possibility to test new families of inhibitors as potential antimalarial drugs. In addition, other key enzymes which play roles in biosynthetic pathways, such as enoyl reductase and chorismate synthase, can be valuable targets for drug development. This review is focused on these protein targets that may help to materialize new generations of antimalarial drugs.
Export Options
About this article
Cite this article as:
de Azevedo Jr. Filgueira Walter, Caceres Andrade Rafael, Pauli Ivani, Timmers S.M. Luis Fernando, Barcellos Barros Guy, Rocha Beiestorf Kelen and Soares Botelho Pereira Milena, Protein-Drug Interaction Studies for Development of Drugs Against Plasmodium falciparum, Current Drug Targets 2009; 10 (3) . https://dx.doi.org/10.2174/138945009787581104
DOI https://dx.doi.org/10.2174/138945009787581104 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tuberculosis of the Thymus: A Case Report and Review of the Literature
Current Respiratory Medicine Reviews Antiviral Activity and Molecular Targets of Plant Natural Products Against Avian Influenza Virus
Current Organic Chemistry Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases
Current Pharmaceutical Biotechnology Fragment-Based Optimization of Small Molecule CXCL12 Inhibitors for Antagonizing the CXCL12/CXCR4 Interaction
Current Topics in Medicinal Chemistry Derivatives of 3-Isoxazolecarboxylic Acid Esters - A Potent and Selective Compound Class against Replicating and Nonreplicating Mycobacterium tuberculosis
Current Topics in Medicinal Chemistry The Use of Biologics for Psoriasis in Asia-Pacific Region
Current Rheumatology Reviews Patents Related to Pathogenic Human Coronaviruses
Recent Patents on Biotechnology Design, Synthesis and Docking Study of Some Novel Isatin- Quinoline Hybrids as Potential Antitubercular Agents
Anti-Infective Agents Mechanism-Based Inactivation of Cytochrome P450 Enzymes: Chemical Mechanisms, Structure-Activity Relationships and Relationship to Clinical Drug-Drug Interactions and Idiosyncratic Adverse Drug Reactions
Current Drug Metabolism Current Therapy in Sarcoidosis, the Role of Existing Drugs and Future Medicine
Inflammation & Allergy - Drug Targets (Discontinued) Heat Shock Protein-60 and Risk for Cardiovascular Disease
Current Pharmaceutical Design Recent Complications and Issues in Tuberculosis Treatment
Recent Patents on Anti-Infective Drug Discovery The Role and Potential Therapeutical Applications of Antimicrobial Proteins in Infectious and Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets EHDA Spraying: A Multi-Material Nano-Engineering Route
Current Pharmaceutical Design 4-Aminoquinoline Based Molecular Hybrids as Antimalarials: An Overview
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Nanotechnology for Drug Delivery Applications)
Current Drug Delivery New Opportunities in the Structure-based Design of Anti-Protozoan Agents
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Medicinal Chemistry Applied to Natural Products in Neglected Drug Discovery)
Combinatorial Chemistry & High Throughput Screening Life Threatening and Fatal Contrast Media Reactions: Pathomechanisms, Diagnosis, Prevention and Drug Management
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Tuberculous Pericarditis
Current Cardiology Reviews